Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan

Bruges 8000

1 studies enrolling now · 3 studies all time

What they study most

Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma, Relapsed Hodgkin Lymphoma, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) — Enrolling by invitation
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed